Out of the 10 analysts covering the stock, seven have a buy rating, two a hold rating while one analyst from Morningstar maintains a sell on the stock with the consensus price target of $35.85.
AFR
https://www.copyright link/companies/financial-services/afterpay-surges-on-goldman-1trn-addressable-market-call-20190925-p52uqg
It a high price but it might be a lot higher if they are buying it now
- Forums
- ASX - By Stock
- Ann: Response to ASX Price Query
Out of the 10 analysts covering the stock, seven have a buy...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online